Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Studies have shown a lower bacteriologic recurrence rate in the treatment of acute streptococcal infections with the intramuscular use of benzathine penicillin ... and 8 were positive for beta ...

Semaglutide, the active ingredient in the weight-loss jab Ozempic, works by mimicking the hormone glucagon-like peptide-1 (GLP-1), helping to control blood sugar levels, slowing down stomach ...

In a world grappling with obesity and chronic disease, GLP-1 drugs like Ozempic are emerging as transformative game-changers. Initially designed for diabetes, these medications now promise ...